Global Iron Deficiency Anemia Therapy Market Size & Outlook
Global iron deficiency anemia therapy market, 2018-2030 (US$M)
Related Markets
Global iron deficiency anemia therapy market highlights
- The global iron deficiency anemia therapy market generated a revenue of USD 4,489.2 million in 2022 and is expected to reach USD 8,062.0 million by 2030.
- The market is expected to grow at a CAGR (2023 - 2030) of 7.6% by 2030.
- In terms of segment, parenteral iron therapy accounted for a revenue of USD 2,729.8 million in 2022.
- Oral Iron Therapy is the most lucrative therapy segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2022.
- Country-wise, U.S. is expected to register the highest CAGR from 2023 to 2030.
Global data book summary
| Market revenue in 2022 | USD 4,489.2 million |
| Market revenue in 2030 | USD 8,062.0 million |
| Growth rate | 7.6% (CAGR from 2022 to 2030) |
| Largest segment | Parenteral iron therapy |
| Fastest growing segment | Oral Iron Therapy |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion, Other Therapies |
Other key industry trends
- In terms of revenue, the North America accounted for 36.6% of the global iron deficiency anemia therapy market in 2022.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, U.S. is the fastest growing regional market and is projected to reach USD 2,532.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Iron Deficiency Anemia Therapy Market Scope
Iron Deficiency Anemia Therapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global iron deficiency anemia therapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to iron deficiency anemia therapy market will help companies and investors design strategic landscapes.
Parenteral iron therapy was the largest segment with a revenue share of 60.81% in 2022. Horizon Databook has segmented the Global iron deficiency anemia therapy market based on oral iron therapy, parenteral iron therapy, red blood cell transfusion, other therapies covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Iron Deficiency Anemia Therapy Therapy Outlook (Revenue, USD Million, 2018-2030)
- Oral Iron Therapy
- Parenteral Iron Therapy
- Red Blood Cell Transfusion
- Other Therapies
- Global Iron Deficiency Anemia Therapy Age Group Outlook (Revenue, USD Million, 2018-2030)
- Adults
- Pediatric
- Geriatric
- Global Iron Deficiency Anemia Therapy End Use Outlook (Revenue, USD Million, 2018-2030)
- Clinics
- Hospitals
- Home Healthcare
Reasons to subscribe to Global iron deficiency anemia therapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global iron deficiency anemia therapy market databook
-
Our clientele includes a mix of iron deficiency anemia therapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global iron deficiency anemia therapy market, including forecasts for subscribers. This global databook contains high-level insights into Global iron deficiency anemia therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global iron deficiency anemia therapy market report size, by regions, 2018-2030 (US$M)
Top 10 countries: Iron deficiency anemia therapy market report size, 2022 (US$M)
Global iron deficiency anemia therapy market report share, by therapy, 2022 & 2030 (%, US$M)
Iron deficiency anemia therapy market: Opportunity assessment by country
Global iron deficiency anemia therapy market, by region, 2022 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
